Supraglottic and Infraglottic Devices Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Expanding Role of Airway Management in the Supraglottic and Infraglottic Devices Market 

The Supraglottic and Infraglottic Devices Market is undergoing significant transformation driven by the global rise in surgical procedures, emergency care cases, and respiratory conditions that demand effective airway control. Devices such as laryngeal mask airways, endotracheal tubes, and oropharyngeal and nasopharyngeal airways are rapidly gaining adoption across hospitals, ambulatory care centers, and emergency response units. 

For instance, the global volume of surgical procedures is projected to exceed 310 million annually, creating substantial need for efficient airway management devices. The increase in road traffic accidents, trauma cases, and cardiovascular emergencies, particularly in developing nations, is contributing to higher deployment of these devices. As the need for quick intubation and lower procedural complications intensifies, the Supraglottic and Infraglottic Devices Market continues to exhibit robust growth across diverse care settings. 

Technological Advancements Catalyzing Growth in the Supraglottic and Infraglottic Devices Market 

The Supraglottic and Infraglottic Devices Market is seeing a strong impact from rapid innovation in product design and materials. For example, modern supraglottic airway devices are increasingly featuring non-inflatable cuffs and anatomically curved shapes, enabling easier insertion and enhanced patient comfort. Similarly, developments in infraglottic devices such as endotracheal tubes with subglottic secretion drainage are helping to reduce ventilator-associated pneumonia, a leading cause of hospital-acquired infections. 

Such innovations are not only improving clinical outcomes but also broadening the applicability of these devices in high-risk patient groups including pediatric, geriatric, and bariatric populations. The market is being further stimulated by the integration of fiber-optic and video technology, which allows real-time visualization during intubation. These advances support the growing adoption of these devices in pre-hospital and military settings, contributing to expanded use cases and higher product penetration in the Supraglottic and Infraglottic Devices Market. 

Increasing Demand in Emergency and Pre-hospital Settings Boosting the Supraglottic and Infraglottic Devices Market 

Emergency medical services have emerged as a critical growth driver for the Supraglottic and Infraglottic Devices Market. With growing urbanization, road traffic density, and trauma incidence, EMS systems across countries are under pressure to deliver fast and reliable airway support. For example, in the United States alone, more than 20 million emergency department visits per year involve respiratory distress or airway compromise, necessitating quick and effective intervention. 

In this context, supraglottic devices such as the i-gel airway and classic laryngeal masks are being extensively utilized for their ease of use and minimal training requirements. Their utility in pre-hospital settings where intubation expertise may be limited makes them a preferred choice. The Supraglottic and Infraglottic Devices Market is seeing increased volume of procurement by ambulance services, paramedic teams, and field emergency units, particularly in regions implementing structured trauma response systems. 

Rising Incidence of Respiratory Diseases Supporting Supraglottic and Infraglottic Devices Market Demand 

Chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and obstructive sleep apnea are increasing worldwide, directly driving the growth of the Supraglottic and Infraglottic Devices Market. According to Datavagyanik, the global COPD burden is expected to reach over 300 million cases by 2030, driven by aging populations, rising tobacco use, and worsening air quality. 

These conditions often result in acute exacerbations requiring airway support, mechanical ventilation, or tracheostomy. Infraglottic devices such as cuffed endotracheal tubes and tracheostomy tubes are critical in managing long-term airway patency in such cases. The Supraglottic and Infraglottic Devices Market is benefiting from increasing hospitalizations linked to respiratory emergencies, particularly among geriatric patients and those with comorbidities such as diabetes or cardiovascular disorders. 

Growing Surgical Volumes Driving Hospital Adoption in the Supraglottic and Infraglottic Devices Market 

Surgical demand is rising globally due to advancements in minimally invasive techniques, aging populations, and increased access to healthcare in emerging economies. With this growth comes the need for reliable airway devices that ensure patient safety during general anesthesia. For instance, in Asia-Pacific, the number of surgical procedures has grown at a CAGR of over 7 percent in the last five years, significantly fueling demand for supraglottic and infraglottic airway devices. 

Hospitals are increasingly integrating these devices into their surgical and post-operative protocols to reduce intubation failures, minimize aspiration risks, and shorten recovery times. As operating rooms prioritize efficiency and patient throughput, the Supraglottic and Infraglottic Devices Market is gaining strategic relevance in institutional procurement plans. 

Expansion of Ambulatory and Day Surgery Centers Strengthening the Supraglottic and Infraglottic Devices Market 

The global shift towards outpatient care and minimally invasive surgeries is reinforcing the value of compact, safe, and easy-to-use airway devices. Ambulatory surgical centers are growing rapidly in both developed and emerging markets, often performing procedures under sedation or general anesthesia that necessitate temporary airway management. 

Devices such as supraglottic laryngeal masks are particularly favored in these settings due to their ability to maintain airway patency without requiring muscle relaxants or deep sedation. The Supraglottic and Infraglottic Devices Market is therefore increasingly aligned with the evolution of day-care surgical practices and enhanced recovery protocols, which aim to reduce hospital stays and healthcare costs. 

Supraglottic and Infraglottic Devices Market Size and Economic Impact 

Datavagyanik projects that the Supraglottic and Infraglottic Devices Market Size will surpass USD 8 billion by 2029, growing at a compound annual growth rate exceeding 6.5 percent. This trajectory is supported by multi-sectoral investment in trauma centers, intensive care units, and surgical infrastructure. 

Key growth regions include North America, Europe, and Asia-Pacific, each contributing significantly to the overall Supraglottic and Infraglottic Devices Market Size through volume expansion, innovation, and favorable reimbursement policies. The market’s contribution to lowering healthcare burden, improving surgical outcomes, and reducing complications positions it as a critical segment within the broader medical device industry. 

Rise of Disposable Devices and Infection Control Awareness in the Supraglottic and Infraglottic Devices Market 

The COVID-19 pandemic placed infection prevention at the forefront of medical practice, leading to increased preference for disposable airway management solutions. Single-use supraglottic and infraglottic devices reduce cross-contamination risks and eliminate the need for sterilization, which is particularly valuable in emergency and outpatient environments. 

Manufacturers are responding by launching cost-effective disposable variants made from biocompatible materials. The Supraglottic and Infraglottic Devices Market is witnessing strong demand from resource-constrained settings that prioritize affordability and infection control. In high-volume ICUs and trauma centers, this shift toward disposables is expected to become a long-term standard, driving sustained market growth. 

Training, Simulation, and Clinical Protocols Elevating Standards in the Supraglottic and Infraglottic Devices Market 

Growing focus on clinician training, simulation-based education, and airway algorithms is positively influencing the Supraglottic and Infraglottic Devices Market. Institutions are increasingly embedding these devices into their advanced life support training and airway management certifications. 

For example, paramedics and anesthesia residents now routinely train with supraglottic devices in simulated emergency scenarios, improving real-world readiness. This focus on competency is enhancing product usage effectiveness, reducing error rates, and fostering a deeper understanding of device selection based on patient physiology and clinical setting. 

“Track Country-wise Supraglottic and Infraglottic Devices Production and Demand through our Database”

• • • Supraglottic and Infraglottic Devices sales volume database for 27+ countries worldwide

Regional Expansion Trends Defining the Supraglottic and Infraglottic Devices Market 

The Supraglottic and Infraglottic Devices Market demonstrates a distinctly regional growth pattern, shaped by differences in healthcare infrastructure, surgical volumes, trauma incidence, and public health funding. North America remains the largest contributor, driven by the United States’ high rate of surgical interventions, emergency services, and established trauma care networks. For instance, over 50 million surgical procedures are performed annually in the U.S., necessitating routine use of both supraglottic and infraglottic airway devices. 

Europe follows closely, where countries like Germany, France, and the UK have strong pre-hospital care systems. These regions are seeing increasing deployment of advanced supraglottic devices in paramedic protocols. Meanwhile, Asia-Pacific represents the most dynamic growth zone within the Supraglottic and Infraglottic Devices Market. Rising healthcare investment in countries such as China and India, coupled with a growing surgical patient base and increased awareness of airway management, is expanding the regional market footprint at a CAGR exceeding 8 percent. 

Latin America and the Middle East are also emerging as promising regions, with rising imports of airway management systems and governmental initiatives focused on trauma and respiratory disease care. This expanding global footprint is a key factor reinforcing the resilient and diversified growth potential of the Supraglottic and Infraglottic Devices Market. 

Supraglottic and Infraglottic Devices Manufacturing Capacity and Innovation Clusters 

Supraglottic and Infraglottic Devices Manufacturing is increasingly becoming concentrated in innovation-led regions, particularly North America and Western Europe, where medical device clusters offer access to skilled labor, R&D infrastructure, and regulatory know-how. For example, Supraglottic and Infraglottic Devices Manufacturing hubs in the U.S., such as those in California and Massachusetts, support ongoing development of disposable, video-assisted, and anatomically customized airway devices. 

In contrast, countries in Asia-Pacific are becoming major centers for large-scale Supraglottic and Infraglottic Devices Manufacturing due to lower production costs and expanding contract manufacturing networks. China and India are playing a pivotal role by providing volume manufacturing for global brands while also fostering domestic producers who cater to rapidly growing regional demand. 

This globalized manufacturing approach enables scalability, price competitiveness, and quick adaptation to evolving clinical needs. Supraglottic and Infraglottic Devices Manufacturing is now integrating lean production practices, automation, and 3D printing to support rapid prototyping and customization, particularly for pediatric and oncology-focused applications. 

Hospital, Pre-Hospital, and ICU Segments Driving Supraglottic and Infraglottic Devices Market Segmentation 

Segmentation within the Supraglottic and Infraglottic Devices Market is sharply defined by end-use application. Hospitals represent the dominant segment, accounting for over 60 percent of global revenue, driven by the sheer scale of surgical interventions, intensive care admissions, and emergency intubations. Devices such as endotracheal tubes, laryngeal masks, and esophageal tracheal combitubes are routinely deployed across operating rooms and critical care units. 

The pre-hospital segment, including ambulance services, disaster response teams, and battlefield medicine, is expanding rapidly, particularly in regions implementing standardized trauma systems. For example, the integration of supraglottic airways in field protocols has significantly reduced pre-hospital mortality from obstructed airways. This segment is forecast to grow at double-digit rates through the end of the decade. 

Another critical driver within the Supraglottic and Infraglottic Devices Market segmentation is the ICU segment, where long-term airway support is required for patients on mechanical ventilation. Tracheostomy tubes and cuffed infraglottic devices are extensively used in these environments, particularly in cases of ventilator-associated respiratory failure, a common outcome in stroke, sepsis, and severe trauma cases. 

Product-Based Segmentation Reshaping the Supraglottic and Infraglottic Devices Market 

Product-type segmentation in the Supraglottic and Infraglottic Devices Market is becoming increasingly granular as clinical protocols grow more sophisticated. Supraglottic devices include laryngeal mask airways, oropharyngeal and nasopharyngeal airways, and newer hybrid devices offering dual ventilation paths. These products are particularly favored in outpatient procedures, emergency response, and short-duration surgeries due to their non-invasive insertion and reduced need for muscle relaxants. 

On the other hand, infraglottic devices such as endotracheal tubes and tracheostomy tubes dominate in high-acuity and long-term care environments. Specialized versions such as reinforced tubes, laser-resistant variants, and suction-enabled designs are creating sub-segments within this category. 

The Supraglottic and Infraglottic Devices Market is also witnessing rising demand for pediatric-specific products that offer safety features for neonates and infants. These include ultra-soft materials, smaller diameters, and integrated oxygen delivery. Such tailored solutions are supporting market differentiation and widening clinical adoption across age groups. 

Disposable vs Reusable Trends Influencing Supraglottic and Infraglottic Devices Market Pricing 

A major trend influencing pricing strategies in the Supraglottic and Infraglottic Devices Market is the shift from reusable to disposable devices. Disposable airway management tools eliminate sterilization costs and reduce cross-infection risks, making them ideal for ambulatory, emergency, and under-resourced healthcare settings. 

For instance, a single-use supraglottic airway device typically costs between USD 5 and USD 20, depending on specifications and features. In contrast, reusable variants, though priced higher initially, require maintenance protocols and have a limited life cycle in high-volume environments. Hospitals are increasingly opting for disposables in high-infection-risk units such as ICUs and emergency departments. 

This dynamic is putting pressure on Supraglottic and Infraglottic Devices Manufacturing firms to optimize cost structures while maintaining product efficacy and compliance. As a result, bulk procurement models, localized manufacturing, and tiered pricing for emerging markets are being adopted across the value chain. 

Pricing Variations Across Geographies in the Supraglottic and Infraglottic Devices Market 

Price sensitivity varies considerably by region, influencing procurement patterns in the Supraglottic and Infraglottic Devices Market. In developed economies like the United States and Germany, price is often secondary to performance and brand reputation. Hospitals in these regions prioritize advanced airway devices with built-in sensors, video laryngoscopy compatibility, and antimicrobial coatings, even at premium price points. 

In contrast, in price-sensitive regions such as Southeast Asia, Sub-Saharan Africa, and parts of Latin America, affordability governs device adoption. This has created a thriving low-cost device segment that is gaining traction due to government tenders and NGO-led healthcare interventions. For example, cost-effective laryngeal masks manufactured in India or China are increasingly being exported to Africa to support expanding surgical and emergency services. 

Datavagyanik notes that balancing performance with affordability is central to sustaining growth in these geographies. This has led to increased focus on locally made, clinically validated products that meet safety standards while remaining cost-accessible. 

OEM Partnerships and Contract Manufacturing Elevating Supraglottic and Infraglottic Devices Manufacturing Efficiency 

OEM partnerships and contract Supraglottic and Infraglottic Devices Manufacturing are playing a crucial role in boosting output while reducing overhead. Large players are increasingly outsourcing non-core manufacturing processes to third-party producers in cost-efficient regions while retaining control over design and quality assurance. 

For example, several European medical device firms have shifted assembly of standard infraglottic tubes to facilities in Southeast Asia to reduce time-to-market. This collaborative model allows manufacturers to respond swiftly to surges in demand, as seen during the peak of the COVID-19 crisis when demand for airway devices surged exponentially. 

Furthermore, this approach supports flexible customization, enabling Supraglottic and Infraglottic Devices Manufacturing units to adapt designs for specific institutional needs such as military medical units, mobile hospitals, and neonatal care. The model also promotes supply chain resilience by diversifying manufacturing bases and minimizing dependency on single regions. 

Regulatory Approvals and Quality Standards Influencing Market Structure 

Compliance with regulatory protocols is a key variable shaping the Supraglottic and Infraglottic Devices Market structure. In high-regulation markets, airway management devices must meet stringent standards related to biocompatibility, sterility, and device tracking. This has raised the entry threshold for new players but has also strengthened trust in clinically validated devices. 

For example, in the U.S., devices must comply with FDA’s Class II device regulations and often undergo 510(k) clearance or PMA reviews. Similarly, CE marking in Europe ensures products meet safety and performance benchmarks before market entry. These frameworks are encouraging investment in R&D and Supraglottic and Infraglottic Devices Manufacturing practices that prioritize quality assurance and traceability. 

In emerging markets, regulatory harmonization with global standards is gradually improving. This shift is expected to enhance cross-border trade and standardize care quality, thereby boosting confidence and expanding access to high-performance devices across the Supraglottic and Infraglottic Devices Market. 

“Supraglottic and Infraglottic Devices Manufacturing Database”

• • • Supraglottic and Infraglottic Devices top manufacturers market share for 27+ manufacturers
    • Top 7 manufacturers and top 17 manufacturers of Supraglottic and Infraglottic Devices in North America, Europe, Asia Pacific
    • Supraglottic and Infraglottic Devices sales dashboard, Supraglottic and Infraglottic Devices sales data in excel format

Top Manufacturers Driving Growth in the Supraglottic and Infraglottic Devices Market 

The Supraglottic and Infraglottic Devices Market is heavily influenced by the strategies and innovations of several major global manufacturers. These companies have established market dominance through a combination of product innovation, strategic acquisitions, regional expansion, and strong distribution networks. Leading players include Medtronic, Teleflex Incorporated, ICU Medical (formerly Smiths Medical), Ambu A/S, Intersurgical Ltd, and Vyaire Medical. Together, these companies control over 60 percent of the total global market, driven by extensive product portfolios and long-standing relationships with hospitals, trauma centers, and surgical facilities. 

Medtronic’s Dominance in the Supraglottic and Infraglottic Devices Market 

Medtronic holds a leading position in the Supraglottic and Infraglottic Devices Market, driven by a strong presence in hospitals and critical care units. The company offers a comprehensive range of endotracheal tubes, cuffed and uncuffed tracheostomy tubes, and surgical airway kits. Its products are widely used for both short-term surgical airway access and long-term respiratory support. The company’s reinforced endotracheal tubes and laser-resistant variants are favored in specialized procedures such as ENT and thoracic surgeries. Medtronic’s focus on integrating clinical safety features, such as subglottic suction and antimicrobial coatings, has enabled it to capture a significant share in high-acuity care environments. 

Teleflex’s Product Lines and Strategic Market Share 

Teleflex Incorporated commands a substantial share of the Supraglottic and Infraglottic Devices Market, particularly through its flagship LMA product line. The LMA Classic, LMA ProSeal, and LMA Supreme are widely recognized in anesthesia and emergency care. These devices offer rapid insertion, minimal trauma, and are designed to reduce the need for muscle relaxants during procedures. Teleflex also offers a growing range of infraglottic devices, including video-enabled endotracheal tubes and single-use variants optimized for infection control. The company’s focus on disposability and high-utility designs has strengthened its market presence across hospitals, ambulatory care units, and EMS providers. 

ICU Medical (Smiths Medical) and its Influence on Infraglottic Segments 

ICU Medical, through its acquisition of Smiths Medical, has a strong footprint in the infraglottic segment of the market. The Portex line of endotracheal and tracheostomy tubes is widely adopted in intensive care units and surgical settings worldwide. These products are available in various sizes and specifications, including wire-reinforced and suction-enabled versions for advanced airway management. ICU Medical continues to innovate in airway kits designed for rapid deployment in emergency settings. The company’s reputation for consistent quality and reliability has ensured strong partnerships with major healthcare institutions, allowing it to maintain a solid share in the Supraglottic and Infraglottic Devices Market. 

Ambu A/S Leading Single-Use Device Innovation 

Ambu A/S is recognized for pioneering single-use, video-enabled airway devices. The company’s VivaSight double-lumen tubes and aScope endoscopy systems have set new standards in visualized airway access, especially in thoracic surgeries and difficult airway cases. Ambu also manufactures a range of supraglottic devices designed for single use, minimizing cross-contamination risks in high-volume hospitals. Its emphasis on ease of use, disposable technology, and integrated visualization is helping to redefine best practices in airway management. Ambu’s expanding portfolio continues to gain traction in North America and parts of Europe, with significant growth potential in Asia-Pacific markets. 

Intersurgical’s i-gel Line Strengthening Supraglottic Segment 

Intersurgical Ltd has carved out a strong niche in the supraglottic segment with its i-gel product line. These non-inflatable devices offer a high-seal solution for spontaneous and controlled ventilation, making them particularly useful in ambulatory surgeries, emergency rooms, and field operations. The company has expanded its range to include pediatric versions and variants compatible with gastric suction, enhancing both safety and versatility. Intersurgical’s focus on anatomical fit and minimal training requirements aligns well with increasing global demand for devices that can be used in both advanced and resource-limited settings. 

Market Share Distribution Across Major Players 

In terms of Supraglottic and Infraglottic Devices Market share, the estimated distribution is as follows: 

• Medtronic: 18 to 20 percent 

• Teleflex Incorporated: 15 to 17 percent 

• ICU Medical (Smiths Medical): 10 to 12 percent 

• Ambu A/S: 7 to 9 percent 

• Intersurgical Ltd: 6 to 8 percent 

• Other manufacturers including Vyaire Medical, Flexicare, and regional players: 30 to 35 percent collectively 

This distribution is influenced by the breadth of product offerings, regulatory approvals, pricing flexibility, and regional access. Companies with diversified portfolios that include both reusable and disposable options are better positioned to capture market opportunities across various healthcare systems. 

Recent Developments in the Supraglottic and Infraglottic Devices Market 

The Supraglottic and Infraglottic Devices Market has seen several notable developments in recent years that indicate an ongoing shift in innovation, partnerships, and product strategy. 

In early 2023, Ambu expanded its VivaSight line with improved visualization capabilities and introduced a new generation of aScope airway endoscopes aimed at intensive care and pulmonology departments. This marks a significant move toward integrating imaging and airway management into a unified system. 

Teleflex continued to expand its reach in the Asia-Pacific region by strengthening distribution of its LMA line and introducing localized versions of its airway devices tailored for regional preferences and regulatory requirements. By late 2022, the company had also launched upgraded single-use laryngoscopes designed for first responders and emergency rooms. 

In 2021, ICU Medical began rolling out updated versions of its Portex tubes with softer, more biocompatible materials, reflecting the market trend toward patient comfort and long-term tolerability. These updates were particularly focused on meeting rising demand in long-stay ICU units and ventilator-dependent patient groups. 

Intersurgical, meanwhile, introduced new variants of the i-gel with integrated suction lines and enhanced ergonomics. The company also increased its presence in Latin America and Eastern Europe, supported by investments in local partnerships and regional warehouses. 

Vyaire Medical and Flexicare also expanded their presence in the pre-hospital segment by introducing low-cost, high-volume supraglottic devices for EMS and rural care units. This is in line with the rising demand for quick, non-invasive airway control in non-hospital settings. 

Outlook for Manufacturers and Strategic Shifts 

As demand continues to rise in emerging economies and specialized care settings, leading manufacturers are likely to increase investments in disposability, video integration, and hybrid airway systems. Market consolidation is also expected as smaller players are acquired or integrated into larger distribution networks. Customization, real-time guidance, and AI-powered airway support tools are expected to define the next evolution of the Supraglottic and Infraglottic Devices Market, placing pressure on manufacturers to innovate across product development, pricing, and training support. 

 

“Supraglottic and Infraglottic Devices Production Data and Supraglottic and Infraglottic Devices Production Trend”

• • • Supraglottic and Infraglottic Devices sales database for historical years, 10 years historical data
    • Supraglottic and Infraglottic Devices sales data and forecast for next 7 years

 

Key Insights that the Supraglottic and Infraglottic Devices Market analysis report presents are:

• Supraglottic and Infraglottic Devices Market revenue and demand by countries
• Supraglottic and Infraglottic Devices Market production and sales volume by countries
• Break-down of the Supraglottic and Infraglottic Devices Market in terms of application areas, target customers and other potential market segments
• Areas that are relatively more potential and are faster growing
• Supraglottic and Infraglottic Devices Market competitive scenario, market share analysis
• Supraglottic and Infraglottic Devices Market business opportunity analysis

 

 

Global and Country-Wise Supraglottic and Infraglottic Devices Market Statistics

• Global and Country-Wise Supraglottic and Infraglottic Devices Market size ($Million) and Forecast – (2021 – 2028)
• Global and Country-Wise Supraglottic and Infraglottic Devices Market Production Volume and Forecast – (2021 – 2028)
• Global and Country-Wise Supraglottic and Infraglottic Devices Market Sales Volume and Forecast – (2021 – 2028)
• Global and Country-Wise Supraglottic and Infraglottic Devices Market Business Opportunity Assessment